Systematic Assessment of Decision-Analytic Models for Chronic Myeloid Leukemia

While several well-designed models of CML treatment strategies exist, there remains a need for the assessment of the long-term efficacy and cost effectiveness of novel treatment options such as second-generation TKIs. Additionally, these models should be validated using independent data. </AbstractSection> Copyright Springer International Publishing Switzerland 2014

MoreLess

Year of publication:	2014
Authors:	Rochau, Ursula ; Schwarzer, Ruth ; Jahn, Beate ; Sroczynski, Gaby ; Kluibenschaedl, Martina ; Wolf, Dominik ; Radich, Jerald ; Brixner, Diana ; Gastl, Guenther ; Siebert, Uwe
Published in:	Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 12.2014, 2, p. 103-115
Publisher:	Springer

Online Resource

Check full text access |

More access options

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10011000873